Study of the influence of isocimonic acid and specialized food products containing it on the dynamics of blood oxygen transport system and hemostasis in professional football players
ORIGINAL PAPERS
Abstract
Introduction. In modern sports medicine, and in football in particular, there is an urgent need to find new safe substances capable of optimizing metabolic processes in athletes under hypoxic conditions during professional workloads. One of the promising substances classified as potential antihypoxants is isocitric acid. It removes the block of succinate dehydrogenase in the Krebs cycle, which reduces the speed of the entire cycle and, consequently, energy production, and also decreases oxygen consumption. Aim. To study the effect of isocitric acid and supplemental nutritional supplement containing it on the dynamics of individual laboratory parameters of the hemostasis, erythropoiesis, and iron metabolism systems. Material and methods. A blinded, randomized, placebo-controlled study of the effect of isocitric acid and supplemental nutritional supplement based on it on the dynamics of individual laboratory parameters of the oxygen transport system and hemostasis was conducted on professional football players during the competitive stage of the annual training cycle. Results. In football players taking 200 mg of isocitric acid, statistically significant changes were observed in oxygen transport system parameters: transferrin saturation percentage and serum iron content decreased, and unsaturated iron-binding capacity of serum increased. In football players taking 100 mg of isocitric acid as part of a supplemental nutritional supplement, hemoglobin levels increased and red blood cell count decreased. In football players taking 200 mg of isocitric acid or 100 mg of isocitric acid as part of a supplemental nutritional supplement, similar dynamics of coagulation parameters were observed: statistically significant increases were observed in activated partial thromboplastin time, international normalized ratios, and prothrombin time, while statistically significant decreases were observed in such parameters as the prothrombin index and fibrinogen, which indicates a targeted effect of isocitric acid on the hemostatic system — hypocoagulation. Conclusion. Isocitric acid improves adaptation to moderate hypoxia, which leads to metabolic restructuring, improved rheological properties of the blood and, as a consequence, to increased performance, especially in anaerobic conditions.
References
1. Авдеева М.Г., Арансон М.В., Безуглов Э.Н. Бушуева Т.В., Ваваев А.В., Виноградов М.А. и др. Практическая спортивная медицина для тренеров. М.: Спорт. 2022. 624 с. Edn: Zuicff.
2. Howarth K.R., Le Blanc P.J., Heigenhauser G.J.F., Gibala M.J. Effect of endurance training on muscle Tca cycle metabolism during exercise in humans. J Appl Physiol. 2004.97(2):579–584. https://doi.org/10.1152/japplphysiol.01344.2003.
3. Ломазова Е.В., Калинин А.В., Слепова Д.А. К вопросу о применении метаболического препарата на различных этапах подготовки высококвалифицированных спортсменов. Медицина. Социология. Философия. Прикладные исследования. 2025.(2):127–130. Edn: Xoagsq.
4. Kamzolova S.V., Morgunov I.G. Microbial production of (2 R,3 S) isocitric acid: state of the arts and prospects. Applied Microbiology and Biotechnology. 2019.103:9321–9333 https://doi.org/10.1007/s00253-019-10207-4.
5. Stoddard B.L., Dean A., Koshland D.E. Structure of isocitrate dehydrogenase with isocitrate, nicotinamide adenine dinucleotide phosphate, and calcium at 2.5 — a resolution: a pseudo Michaelis ternary complex. Biochemistry. 1993.32:9310–9316. https://doi.org/10.1021/bi00087a008.
6. Колонтьева Н.А. Малые молекулы — переключатели обмена веществ. Дис. д ра. ... мед. наук. Самара. 2021. 297 с.
7. R Core Team. stats: Wilcoxon Rank Sum and Signed Rank Tests (wilcox.test). In: R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. 2025. Url: https://www.rdocumentation.org/packages/stats/topics/wilcox.test_ (дата_обращения:_12.03.2026).
8. dplyr: Wickham H., François R., Henry L., Müller K. dplyr: A Grammar of Data Manipulation. R package version 1.1.4. 2023. https://cran.r_project.org/package=dplyr_(дата_обращения:_12.03.2026).
9. Peeling P., Dawson B., Goodman C., Landers G., Trinder D. Athletic induced iron deficiency: new insights into the role of inflammation, cytokines and hormones. Eur J Appl Physiol. 2008.103(4):381–391. https://doi.org/10.1007/s00421-008-0726-6.
10. Sim M., Garvican Lewis L.A., Cox G.R., Govus A., Mc Kay A.K.A., Stellingwerff T., Peeling P. Iron considerations for the athlete: a narrative review. Eur J Appl Physiol. 2019.119(7):1463–1478. https://doi.org/10.1007/s00421-019-04157_y.
11. Camaschella C., Pagani A. Iron and erythropoiesis: a dual relationship. Int J Hematol. 2011.93(1):21–26. https://doi.org/10.1007/s12185-010-0743-1.
12. Koury M.J., Ponka, P. New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annu Rev Nutr. 2004.24:105–131. https://doi.org/10.1146/annurev.nutr.24.012003.132306.
13. Simmonds M.J. Blood rheology and aging. J Geriatr Cardiol. 2013.10(3):291–301. https://doi.org/10.3969/j.issn.1671-5411.2013.03.010.
14. Lippi G., Salvagno G.L., Montagnana M., Schena F., Ballestrieri F., Guidi G.C. Influence of physical exercise and relationship with biochemical variables of Nt pro brain natriuretic peptide and ischemia modified albumin. Clin Chim Acta. 2006.367(1-2):175–180. https://doi.org/10.1016/j.cca.2005.11.018.
15. Robach P., Lafforgue E., Olsen N.V., Déchaux M., Fouqueray B., Westerterp Plantenga M., Westerterp K., Richalet J.P. Recovery of plasma volume after 1 week of exposure at 4,350 m. Pflugers Arch. 2002.444(6):821–828. https://doi.org/10.1007/s00424-002-0894_x.
16. Menzel K., Hilberg T. Blood coagulation and fibrinolysis in healthy, untrained subjects: effects of different exercise intensities controlled by individual anaerobic threshold. Eur J Appl Physiol. 2011.111(2):253–260. https://doi.org/10.1007/s00421-010-1640-2.
17. Smith J.E. Effects of strenuous exercise on haemostasis. Br J Sports Med. 2003.37(5):433–435. https://doi.org/10.1136/bjsm.37.5.433.
18. Mercer K.W., Densmore J.J. Hematologic disorders in the athlete. Clin Sports Med. 2005.24(3):599–621, ix. https://doi.org/10.1016/j.csm.2005.03.006.



